Effect of PARP inhibitors on sensitivity of lung and breast cancer cells to trans-platinum as compared to cis-platinum.

被引：0
|
作者：
Jankovic, Radmila [1 ]
Radulovic, Sinisa [1 ]
Arandjelovic, Sandra [1 ]
Filipovic, Lana [1 ]
机构：
[1] Inst Oncol & Radiol Serbia, Dept Expt Oncol, Belgrade, Serbia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e22115
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The effect of histone deacetylase inhibition on BRCA1 expression: A potential novel mechanism for enhancing platinum sensitivity in breast and ovarian cancer
    Weberpals, Johanne I.
    O'Brien, Anna
    Garbuio, Kyla
    Clark-Knowles, Katherine
    Dimitroulakos, Jim
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [32] Antitumor effect and mechanisms research of the PARP inhibition combination with platinum salts and PI3K inhibition on human triple negative breast cancer cell
    Zhang, Jin
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] Immune checkpoint inhibitors plus platinum-based chemotherapy compared to platinum-based chemotherapy with or without bevacizumab for first-line treatment of older people with advanced non-small cell lung cancer
    Orillard, Emeline
    Adhikari, Arjab
    Malouf, Reem S.
    Calais, Francois
    Marchal, Corynne
    Westeel, Virginie
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2024, (08):
  • [34] ANTITUMOR STEROIDAL CIS-PLATINUM(II) ORTHO-CATECHOLATO CONJUGATES - PRELIMINARY EVALUATION ON BREAST-CANCER MCF-7 CELLS
    GANDOLFI, O
    BLUM, J
    MANDELBAUMSHAVIT, F
    INORGANICA CHIMICA ACTA-BIOINORGANIC CHEMISTRY, 1984, 91 (04): : 257 - 261
  • [35] The Effect of Acquired Cisplatin Resistance on Sensitivity to EGFR Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Cells
    Rho, Jin Kyung
    Choi, Yun Jung
    Choi, You Ri
    Kim, Sun Ye
    Choi, Su Jin
    Choi, Chang-Min
    Na, Im Il
    Lee, Jae Cheol
    ONCOLOGY RESEARCH, 2011, 19 (10-11) : 471 - 478
  • [36] CSB affected on the sensitivity of lung cancer cells to platinum-based drugs through the global decrease of let-7 and miR-29
    Zhenbang Yang
    Chunling Liu
    Hongjiao Wu
    Yuning Xie
    Hui Gao
    Xuemei Zhang
    BMC Cancer, 19
  • [37] CSB affected on the sensitivity of lung cancer cells to platinum-based drugs through the global decrease of let-7 and miR-29
    Yang, Zhenbang
    Liu, Chunling
    Wu, Hongjiao
    Xie, Yuning
    Gao, Hui
    Zhang, Xuemei
    BMC CANCER, 2019, 19 (01)
  • [38] Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC): retrospective multicentric analysis of post-progression treatments
    Valenza, Carmine
    Trapani, Dario
    Gandini, Sara
    Sposetti, Caterina
    Bielo, Luca Boscolo
    Marra, Antonio
    Giarratano, Tommaso
    Favero, Diletta
    Cortesi, Laura
    Moscetti, Luca
    Pistelli, Mirco
    Berardi, Rossana
    Zambelli, Alberto
    Lambertini, Matteo
    Del Mastro, Lucia
    Guarneri, Valentina
    Vernieri, Claudio
    Curigliano, Giuseppe
    EUROPEAN JOURNAL OF CANCER, 2023, 190
  • [39] HSP90 inhibitor 17-allylamino-geldanamycin enhances sensitivity to double-strand DNA break-inducing agents (platinum and PARP inhibitors) in epithelial ovarian cancer.
    Battelli, Chiara
    Morse, Alexander
    Hu, Hai
    Levantini, Elena
    Wulf, Gerburg
    Konstantinopoulos, Panagiotis A.
    CANCER RESEARCH, 2013, 73 (08)
  • [40] THE EFFECT OF ACQUISITION OF CISPLATIN-RESISTANCE ON SENSITIVITY TO EGFR TYROSINE KINASE INHIBITORS IN EGFR MUTANT LUNG CANCER CELLS
    Lee, J. C.
    Rho, J. K.
    Choi, Y. J.
    Koh, J. S.
    Chung, H. S.
    ANNALS OF ONCOLOGY, 2010, 21 : 61 - 61
12345